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Caroline Sutcliffe4, Karen Davies4 and Richard Byng5
Dear editors,
We read with interest the recent article regarding the
lack of inclusion of people who lack capacity in trials:
‘Protection by exclusion? The (lack of) inclusion of
adults who lack capacity to consent in clinical trials in
the UK’ [1]. As the authors so eloquently spotlight, those
without capacity in many population groups are those
who are likely to be most vulnerable to frailty, comor-
bidities and isolation. Their exclusion from research sig-
nificantly limits the specific evidence base for their care.
As a research team developing and evaluating a Demen-
tia Support Worker intervention based in primary care,
we appreciate the challenges of including people in com-
plex dementia interventions research who are most likely
to benefit from the intervention. We are mindful of
one of five ‘Dementia statements’, developed by
people living with dementia and grounded in Human
Rights law: ‘We have a right to know about and de-
cide if we want to be involved in research that looks
at cause, cure and care for dementia and be sup-
ported to take part’ [1].
We wished to develop an ethical recruitment process
that enabled us to involve and understand the barriers to
involvement of hard-to-reach groups of people with
dementia: those who lack capacity but also those who lack
support networks and experience frailty and emotional
difficulties. We have developed a person-centred flexible
recruitment pathway in consultation with our Patient and
Public Involvement (PPI) group (including people with
dementia and carers). The approach involves the practice
team, Clinical Research Network (CRN), staff, and the
research team working seamlessly together. The approach
is pro-active, using a combination of letters, phone calls,
invites to clinics and a home visit as appropriate and
depending on the response at each stage. Many people
with dementia do not necessarily read or understand
letters, so we cannot assume that no response means
engagement in decision-making about involvement. At
the same time, we aim to avoid unwelcome pursuit;
declining to take part results in no further contact, and
involvement requires actively opting in.
A key principle of the Mental Capacity Act [3] is that
individuals must be supported to understand information
relevant to a decision, retain information, weigh up that
information and communicate a decision by any means
possible. Where people lack capacity, a personal consultee
can be involved in decision-making based on prior
knowledge of the person’s preferences and values. The
Department of Health [2] provides guidance on
nominating a consultee. This is not without challenges.
Capacity can fluctuate over time. Also, a person’s
personality, preferences and values may change as the
dementia progresses. Those who may have been willing to
engage in research may become more suspicious and
unwilling, for instance. These dilemmas will need to be
addressed on a case-by-case basis, but even if a consultee
is involved, the role of verbal and non-verbal signs of
assent from the person with dementia should not be
ignored.
In order to try to address some of these challenges,
our recruitment pathway allows ongoing assessment of
the nature of family support and barriers to involvement,
over time and prior to consent. Judgements about
capacity and about who might reasonably act as
consultee will result from this ongoing process and from
developing an understanding of an individual’s commu-
nication abilities and needs, rather than relying on a test
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score on one day at one time. Crucially, if there is no
response from an eligible participant at any of the stages
of the pathway, a clinical home visit is built in. This will
involve a clinical assessment first in case there are
unknown needs.
Our journey through the ethics process has been
challenging. Pre-trial development work for both
intervention and trial procedures is not well understood.
We were also very aware that there have been different
views about whether CRN staff can access clinical re-
cords or make telephone calls prior to consent. The first
panel we applied to gave an unfavourable opinion. As
our intervention was not fully developed, it was advised
that we should initially recruit only those with capacity.
Of course, there are some research designs that require
only participants with intact cognition, depending on the
demands of participation, but to exclude those who lack
capacity in our study would have been highly restricting
in terms of the population we are aiming to support.
Our PPI group expressed incomprehension at this stage:
‘It feels unethical to exclude them’ ‘How do you ever
change things for people without capacity?’ The panel
also said that only the practice team should approach
individuals prior to consent, making the role of CRN
staff redundant. A favourable opinion was given by a
second panel, who recognised the process of complex
intervention development and advised that we should
recruit people who lack capacity. They identified an
ethical imperative to do this. They also recognised that
research network staff could be incorporated into an
enhanced primary care team and so ensure that the
process would not be affected by the primary care
workforce crisis.
Shepherd et al. (2019) have provided a catalyst for in-
creased awareness, debate and action in this important
area. Through our feasibility phase, we are currently
testing out our approach to recruitment and look
forward to contributing to this debate by sharing what
we learn from this process.
A wider challenge for the future will be around
improving consistency of interpretation and advice from
ethics panels so that hard-to-reach groups are enabled
to take part in intervention development research.
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